MediWound

DEBx Medical

This company develops chemical debridement agents for healthcare professionals to treat chronic wounds by removing infection and biofilm.

Onya

This biotechnology company develops advanced therapies and medical dressings to treat chronic and acute wounds for patients with delayed healing.

Krystal Biotech

This biotechnology company develops and commercialises redosable gene therapies for patients with rare genetic diseases, including dystrophic epidermolysis bullosa.

Aurealis Pharma

This company develops cell and gene therapies for patients suffering from chronic wounds, cancer and inflammatory diseases.

PainReform

This pharmaceutical company develops extended-release anesthetic formulations to provide post-operative pain relief for surgical patients and reduce opioid dependency.

Ultragenyx

This biopharmaceutical company develops and commercialises therapies for patients with serious rare and ultra-rare genetic diseases.

Arcutis Biotherapeutics

This biopharmaceutical company develops and commercialises topical treatments for patients with chronic inflammatory skin diseases such as psoriasis, eczema, and seborrhoeic dermatitis.

Plasmacure

This company develops cold plasma medical devices for healthcare professionals to treat chronic wounds such as diabetic foot ulcers and pressure sores.